Novoxel® is a pioneering brand in the field of fractional skin rejuvenation. Established in 2011, Novoxel® aims to revolutionize aesthetic treatments by developing innovative solutions for both physicians and patients. The company collaborates closely with the medical community and boasts leading physicians on its advisory panel.

One of Novoxel's® game-changing technologies is TMA™, which offers safe and versatile fractional skin resurfacing. This patient-friendly technology has been proven effective through multiple clinical studies published in reputable journals. Novoxel's® patented products and technology are now marketed in over 30 countries worldwide.

At the heart of Novoxel's® product lineup is their flagship aesthetic platform, Tixel®. This compact and user-friendly device utilizes TMA™ technology to regenerate and heal the skin effectively. Tixel® offers quick and noticeable results with minimal downtime, making it suitable for treating various body areas.

With a focus on excellence and innovation, Novoxel® continues to redefine the aesthetics industry by pushing boundaries and developing novel solutions. Choose Novoxel® for a greener, safer, and more effective approach to skin rejuvenation